Cigna Group $CI Shares Sold by Artisan Partners Limited Partnership

Artisan Partners Limited Partnership trimmed its position in Cigna Group (NYSE:CI) by 2.0% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 402,322 shares of the health services provider’s stock after selling 8,220 shares during the period. Artisan Partners Limited Partnership owned 0.15% of Cigna Group worth $133,000,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD grew its position in shares of Cigna Group by 10.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after acquiring an additional 1,094,327 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its stake in Cigna Group by 1.1% during the second quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock worth $3,893,727,000 after purchasing an additional 123,479 shares during the last quarter. Dodge & Cox boosted its holdings in Cigna Group by 1.3% in the first quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider’s stock worth $2,924,722,000 after purchasing an additional 117,125 shares during the period. GQG Partners LLC increased its stake in Cigna Group by 21.5% during the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares during the last quarter. Finally, Valeo Financial Advisors LLC raised its holdings in shares of Cigna Group by 86,071.1% during the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after purchasing an additional 3,471,249 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In related news, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO David Cordani bought 4,134 shares of the business’s stock in a transaction on Monday, November 3rd. The stock was purchased at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the transaction, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This trade represents a 2.69% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a report on Thursday, November 13th. Jefferies Financial Group restated a “buy” rating and issued a $310.00 target price on shares of Cigna Group in a research note on Monday, November 3rd. Cantor Fitzgerald dropped their price target on Cigna Group from $365.00 to $325.00 in a research report on Friday, October 31st. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Finally, TD Cowen dropped their target price on Cigna Group from $387.00 to $333.00 and set a “buy” rating on the stock in a research report on Tuesday, November 4th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $334.05.

Cigna Group Stock Performance

Shares of CI stock opened at $272.11 on Thursday. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm has a market capitalization of $72.69 billion, a price-to-earnings ratio of 14.85, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44. The business has a 50 day simple moving average of $287.96 and a 200 day simple moving average of $299.78.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. The company had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities research analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be paid a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 annualized dividend and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is presently 26.64%.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.